BANK VONTOBEL/CALL/ELI LILLY & CO/420/0.1/21.06.24 Share Price

Warrant

DE000VU6BRA7

Market Closed - Deutsche Boerse AG 11:23:05 24/05/2024 pm IST
36.14 EUR -0.22% Intraday chart for BANK VONTOBEL/CALL/ELI LILLY & CO/420/0.1/21.06.24
Current month+6.80%
1 month+20.51%
Date Price Change
24/24/24 36.14 -0.22%
23/24/23 36.22 +2.78%
22/24/22 35.24 -1.95%
21/24/21 35.94 +6.87%
20/24/20 33.63 +2.88%

Delayed Quote Deutsche Boerse AG

Last update May 24, 2024 at 11:23 pm IST

More quotes

Static data

Product typeWarrants
Buy / SellCALL
Underlying ELI LILLY AND COMPANY
IssuerLogo Issuer Vontobel Vontobel
WKN VU6BRA
ISINDE000VU6BRA7
Date issued 17/04/2023
Strike 420 $
Maturity 21/06/2024 (28 Days)
Parity 10 : 1
Emission price 3.14
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 36.61
Lowest since issue 2.96
Delta0.99x
Omega 2.037
Premium0.41x
Gearing2.07x
Moneyness 1.922
Difference Strike -387.4 $
Difference Strike %-92.25%
Spread 0.02
Spread %0.06%
Intrinsic value 35.72

Company Profile

Eli Lilly and Company is one of the world's leading pharmaceutical groups. Net sales break down by therapeutic field as follows: - endocrinology (57.7%): products for treating osteoporosis, diabetes, and growth problems; - oncology (19.5%); - immunology diseases (11.1%); - neurology (8.4%): primarily drugs used in treating depression and schizophrenia; - other (3.3%). Net sales are distributed geographically as follows: the United States (63.9%), Europe (18.1%), Japan (4.9%), China (4.5%) and other (8.6%).
Sector
-
More about the company

Ratings for Eli Lilly and Company

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: Eli Lilly and Company

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
807.4 USD
Average target price
850.8 USD
Spread / Average Target
+5.37%
Consensus